Literature DB >> 6427931

Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience.

L Leichman, Z Steiger, H G Seydel, V K Vaitkevicius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427931

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  12 in total

Review 1.  Light at the end of the tunnel? Palliation for oesophageal carcinoma.

Authors:  J Cox; J R Bennett
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

2.  [Preoperative chemotherapy in esophageal cancer: an advantage or danger for surgical intervention?].

Authors:  P Schlag; R Herrmann; U Raeth; B Lehner; V Schwarz; C Herfarth
Journal:  Langenbecks Arch Chir       Date:  1987

Review 3.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

Review 4.  Adjuvant therapies for cancer of the thoracic esophagus.

Authors:  T Nishihira; T Nakano; S Mori
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

Review 5.  Lymph node dissection.

Authors:  T P Hennessy
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

6.  First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.

Authors:  E Ancona; A Ruol; C Castoro; V Chiarion-Sileni; S Merigliano; S Santi; L Bonavina; A Peracchia
Journal:  Ann Surg       Date:  1997-12       Impact factor: 12.969

Review 7.  Cancer of the esophagus: the Wayne State University experience.

Authors:  L Leichman
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

8.  A randomized comparison of dilatation alone versus dilatation plus laser in patients receiving chemotherapy and external beam radiation for esophageal carcinoma.

Authors:  B S Anand; Z A Saeed; P A Michaletz; C B Winchester; M A Doherty; J H Liem; D Y Graham
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

9.  Achalasia combined with esophageal cancer treated by concurrent chemoradiation therapy.

Authors:  Jun Chul Park; Yong Chan Lee; Sang Kyum Kim; Yu Jin Kim; Sung Kwan Shin; Sang Kil Lee; Hoguen Kim; Choong Bai Kim
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

10.  Palliation of inoperable esophageal carcinoma. Therapeutic endoscopy as an adjunct to combined chemotherapy and radiotherapy.

Authors:  R S Chung; C E Bredenberg; D A Churchill
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.